Korean drugmakers urged to develop first generic versions

In Korea, considered one of Asia's top pharmacy markets, the size is expected to go up 9 percent to almost 12 trillion won this year.

Along with the sizeable jump, the competition between local and global makers will heat up even more.

Korea's complete market liberalization in the late 1990s exposed the domestic pharmaceutical industry to direct competition from multinational firms that ...